Capital Advisors, Ltd. LLC Applied Therapeutics Inc. Transaction History
Capital Advisors, Ltd. LLC
- $811 Million
- Q2 2025
A detailed history of Capital Advisors, Ltd. LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 2,367 shares of APLT stock, worth $1,136. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,367
Previous 1,839
28.71%
Holding current value
$1,136
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding APLT
# of Institutions
94Shares Held
103MCall Options Held
176KPut Options Held
165K-
Vestal Point Capital, LP New York, NY11.5MShares$5.52 Million0.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$5.42 Million6.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.4MShares$4.98 Million0.0% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$3.74 Million2.55% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$3.15 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $23M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...